Infinant Health, Inc.

Infinant Health is a privately held biotechnology company dedicated to revolutionizing human health through the development of microbiome-based solutions. The company focuses on improving infant health by harnessing the power of beneficial bacteria found in breast milk. Infinant Health's mission is to change the trajectory of human health, one baby at a time, by unlocking the full potential of the infant gut microbiome. The company's flagship product, Evivo, is a probiotic designed to restore the balance of beneficial bacteria in infants, promoting better digestion, immunity, and overall health.

Product/Service Line Breakdown:

1. Evivo Probiotic
  - A probiotic supplement specifically designed for infants. It contains the beneficial bacterium Bifidobacterium longum subsp. infantis (B. infantis), which helps to restore the natural balance of the gut microbiome when combined with breast milk. This product aims to improve digestion, enhance immune function, and support overall infant health.

2. Microbiome Research and Development
  - Ongoing research and development efforts focused on understanding the infant gut microbiome and its impact on health. This includes clinical studies and partnerships with academic institutions to advance knowledge in the field of microbiome science.

3. Educational Resources
  - Providing parents and healthcare providers with comprehensive educational materials about the importance of the infant gut microbiome, the role of probiotics, and the benefits of using Evivo. This includes online resources, webinars, and informational guides.

4. Healthcare Professional Support
  - Dedicated support services for healthcare professionals, including training, clinical resources, and assistance with integrating microbiome-based solutions into pediatric care practices.